JP2024511473A5 - - Google Patents
Info
- Publication number
- JP2024511473A5 JP2024511473A5 JP2023558979A JP2023558979A JP2024511473A5 JP 2024511473 A5 JP2024511473 A5 JP 2024511473A5 JP 2023558979 A JP2023558979 A JP 2023558979A JP 2023558979 A JP2023558979 A JP 2023558979A JP 2024511473 A5 JP2024511473 A5 JP 2024511473A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- formula
- sirna molecule
- ribonucleoside
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163165543P | 2021-03-24 | 2021-03-24 | |
| US63/165,543 | 2021-03-24 | ||
| PCT/US2022/021790 WO2022204430A1 (en) | 2021-03-24 | 2022-03-24 | Double-stranded sirna having patterned chemical modifications |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511473A JP2024511473A (ja) | 2024-03-13 |
| JP2024511473A5 true JP2024511473A5 (cg-RX-API-DMAC7.html) | 2025-04-01 |
Family
ID=83397880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023558979A Pending JP2024511473A (ja) | 2021-03-24 | 2022-03-24 | パターン化化学修飾を有する二本鎖sirna |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240182892A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4313075A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024511473A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117597133A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022242899A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3214660A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022204430A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024073595A2 (en) * | 2022-09-28 | 2024-04-04 | Atalanta Therapeutics, Inc. | Compositions and methods for treatment of huntington's disease |
| CN118202055A (zh) * | 2023-02-17 | 2024-06-14 | 苏州时安生物技术有限公司 | 一种抑制SCN9A基因表达的siRNA、其药物组合物及用途 |
| KR20260112707A (ko) * | 2023-10-18 | 2026-07-20 | 유니버시티 오브 매사추세츠 | 에틸렌 글라이콜이 개질된 올리고뉴클레오타이드 |
| TW202521696A (zh) * | 2023-11-20 | 2025-06-01 | 大陸商上海舶望製藥有限公司 | 抑制鈉電壓門控通道α亞基9(SCN9A)表達的組合物和方法 |
| WO2025196505A2 (en) | 2024-03-22 | 2025-09-25 | Takeda Pharmaceutical Company Limited | Compositions and methods for inhibiting cytochrome p450 family 7 subfamily a member 1 (cyp7a1) expression |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9181551B2 (en) * | 2002-02-20 | 2015-11-10 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| BR112015013105B1 (pt) * | 2012-12-05 | 2022-02-08 | Alnylam Pharmaceuticals, Inc | Agente de rnai de fita dupla capaz de inibir a expressão de pcsk9, seus usos, composição farmacêutica e método de inibição da expressão de pcsk9 em uma célula in vitro |
| EP3929293A3 (en) * | 2015-04-03 | 2022-03-16 | University Of Massachusetts | Fully stabilized asymmetric sirna |
| BR112017021053A2 (en) * | 2015-04-13 | 2018-08-14 | Alnylam Pharmaceuticals, Inc. | angiopoietin type 3 (angpt13) irna compositions and methods of use thereof |
| LT3329002T (lt) * | 2015-07-31 | 2021-01-11 | Alnylam Pharmaceuticals, Inc. | Transtiretino (ttr) irnr kompozicijos ir jų naudojimo būdai, skirti naudoti su ttr susijusių ligų gydymui arba prevencijai |
| US11015198B2 (en) * | 2017-04-05 | 2021-05-25 | Silence Therapeutics Gmbh | Products and compositions |
| WO2018237245A1 (en) * | 2017-06-23 | 2018-12-27 | University Of Massachusetts | TWO TAIL SELF-ADMINISTRATION SIRNA AND ASSOCIATED METHODS |
| SG11202003082UA (en) * | 2017-11-13 | 2020-05-28 | Silence Therapeutics Gmbh | Nucleic acids for inhibiting expression of a target gene comprising phosphorodithioate linkages |
| CA3133241A1 (en) * | 2019-03-15 | 2020-09-24 | University Of Massachusetts | Oligonucleotides for tissue specific apoe modulation |
| AU2020252020A1 (en) * | 2019-03-29 | 2021-11-11 | University Of Massachusetts | Oligonucleotide-based modulation of C90RF72 |
| US20210115442A1 (en) * | 2019-08-23 | 2021-04-22 | University Of Massachusetts | O-methyl rich fully stabilized oligonucleotides |
-
2022
- 2022-03-24 EP EP22776673.0A patent/EP4313075A4/en active Pending
- 2022-03-24 CA CA3214660A patent/CA3214660A1/en active Pending
- 2022-03-24 WO PCT/US2022/021790 patent/WO2022204430A1/en not_active Ceased
- 2022-03-24 AU AU2022242899A patent/AU2022242899A1/en active Pending
- 2022-03-24 US US18/283,666 patent/US20240182892A1/en active Pending
- 2022-03-24 JP JP2023558979A patent/JP2024511473A/ja active Pending
- 2022-03-24 CN CN202280037397.4A patent/CN117597133A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6647430B2 (ja) | アンチセンス核酸 | |
| JP6701139B2 (ja) | アンチセンス核酸 | |
| CN110055243B (zh) | 反义核酸 | |
| JP6977998B2 (ja) | アンチセンス核酸 | |
| US10538763B2 (en) | Compounds and methods for modulation of DUX4 | |
| JP2025165976A5 (cg-RX-API-DMAC7.html) | ||
| JP2021533804A5 (cg-RX-API-DMAC7.html) | ||
| CN107532162A (zh) | 用于利用寡核苷酸编辑细胞中核酸的组合物和方法 | |
| WO2015137409A1 (ja) | アンチセンス核酸 | |
| JP2021072862A (ja) | B型肝炎感染の治療用のPAPD5及びPAPD7 mRNAを低減させるための核酸分子 | |
| JP2024521897A5 (cg-RX-API-DMAC7.html) | ||
| CN113454221A (zh) | 含有三元环的双链核酸抑制剂分子 | |
| US12529053B2 (en) | Double-stranded nucleic acid inhibitor molecules with shortened sense strands | |
| JPWO2019022196A1 (ja) | 一本鎖オリゴヌクレオチド | |
| JP2021515784A5 (cg-RX-API-DMAC7.html) | ||
| CN114901823A (zh) | 诱导外显子50的跳读的反义核酸 | |
| JP2024542738A5 (cg-RX-API-DMAC7.html) | ||
| JP7737667B2 (ja) | 核酸複合体 | |
| CN115210376A (zh) | 诱导外显子51的跳读的反义核酸 | |
| JP2024512612A5 (cg-RX-API-DMAC7.html) | ||
| CN121311592A (zh) | 用于调节jak1表达的双链寡核苷酸 | |
| JP2025517341A5 (cg-RX-API-DMAC7.html) | ||
| RU2025110470A (ru) | КОМПОЗИЦИИ миРНК И СПОСОБЫ ДЛЯ НАЦЕЛИВАНИЯ НА НУКЛЕИНОВЫЕ КИСЛОТЫ БЕЛКА ТАУ, АССОЦИИРОВАННОГО С МИКРОТРУБОЧКАМИ | |
| RU2025110478A (ru) | КОМПОЗИЦИИ миРНК И СПОСОБЫ ДЛЯ НАЦЕЛИВАНИЯ НА НУКЛЕИНОВЫЕ КИСЛОТЫ АЛЬФА-СИНУКЛЕИНА | |
| WO2024228398A1 (ja) | グアニン四重鎖構造を誘導するための核酸剤 |